Filing Flows › Comparisons › ARCT vs TNXP
Arcturus Therapeutics Holdings vs Tonix Pharmaceuticals Holding: ARCT and TNXP compared
Arcturus Therapeutics Holdings is the larger company: $18.3M of revenue in its latest quarter (Q3 2026) against $17.2M for Tonix Pharmaceuticals Holding (Q3 2026). Tonix Pharmaceuticals Holding is growing faster (+424% against +7% a year earlier). Arcturus Therapeutics Holdings is more profitable, with an operating margin of -50.2% against -321.6%.
Where the money goes: ARCT and TNXP
Arcturus Therapeutics Holdings (ARCT) · Q3 2026
Arcturus Therapeutics Holdings, Q3 2026: revenue $18.3M (+7% year over year), operating margin -50.2%, net loss $7.4M, operating cash flow −$6.9M. The chart follows the revenue to costs, profit and cash.
Tonix Pharmaceuticals Holding (TNXP) · Q3 2026
Tonix Pharmaceuticals Holding, Q3 2026: revenue $17.2M (+424% year over year), operating margin -321.6%, net loss $53.3M, operating cash flow −$41.1M. The chart follows the revenue to costs, profit and cash.
| Arcturus Therapeutics Holdings (ARCT) | Tonix Pharmaceuticals Holding (TNXP) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $18.3M | $17.2M |
| Revenue growth, Y/Y | +7% | +424% |
| Operating margin | -50.2% | -321.6% |
| Net earnings | −$7.4M | −$53.3M |
| Net margin | -40.5% | -309.4% |
| Operating cash flow | −$6.9M | −$41.1M |
Where the revenue comes from
Arcturus Therapeutics Holdings
- Collaboration Revenue: $16.9M (92%)
- Grant: $1.4M (8%)
Tonix Pharmaceuticals Holding
- Tonmya: $15.0M (87%)
- Zembrace Symtouch: $1.5M (9%)
- Tosymra: $689K (4%)
Questions
Which is bigger, Arcturus Therapeutics Holdings or Tonix Pharmaceuticals Holding?
Arcturus Therapeutics Holdings is the larger company: $18.3M of revenue in its latest quarter (Q3 2026) against $17.2M for Tonix Pharmaceuticals Holding (Q3 2026).
Is Arcturus Therapeutics Holdings or Tonix Pharmaceuticals Holding growing faster?
Tonix Pharmaceuticals Holding is growing faster (+424% against +7% a year earlier).
Which is more profitable, Arcturus Therapeutics Holdings or Tonix Pharmaceuticals Holding?
Arcturus Therapeutics Holdings is more profitable, with an operating margin of -50.2% against -321.6%.
More: Arcturus Therapeutics Holdings earnings · how Arcturus Therapeutics Holdings makes money · Tonix Pharmaceuticals Holding earnings · how Tonix Pharmaceuticals Holding makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.